Close mobile menu×
Close mobile menu

Mary R. Welch, MD

Board Certifications: 
Neurology
Expertise in: 
Neuro-Oncology, Brain & Spinal Tumors
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 
(212) 342-0571

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Neurology

Clinical Expertise

  • Neuro-Oncology
  • Brain & Spinal Tumors
  • Acoustic Neuroma
  • Astrocytoma
  • Anaplastic Astrocytoma
  • Brain Cancer
  • Brain Metastases
  • Brain Stem Glioma
  • Brain Tumor
  • Carcinomatous meningitis
  • Chordoma
  • Choroid Plexus Carcinoma
  • Choroid Plexus Papilloma
  • Ependymoma
  • Glioblastoma
  • Gliomas
  • Hemangioblastoma
  • Leptomeningeal metastases
  • Medulloblastoma
  • Meningioma
  • Metastatic Cancer
  • Mixed Glioma
  • Neurofibromatosis
  • Oligodendroglioma
  • Oligoastrocytoma
  • Glioblastoma Multiforme
  • Spinal Cord Tumor
  • Second Opinion
  • Spinal Tumors

Specialties

Education & Training

  • MD, Northwestern University Feinberg School of Medicine
  • Internship: New York University Langone Medical Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: Memorial Sloan-Kettering Cancer Center

Honors & Awards

ASCO Conquer Cancer Foundation Merit Award

Comparative Effectiveness Research Award

Arnold P. Gold Humanism and Excellence in Teaching Award

About Mary Welch

Mary Welch, MD is an Assistant Professor of Neurology at CUMC, in the Division of Neuro-Oncology. Dr. Welch graduated from Chicagos' Northwestern Feinberg School of Medicine. She completed neurology residency here at Columbia, followed by sub-specialty training in neuro-oncology at Memorial Sloan-Kettering Cancer Center. In her second year of fellowship, she earned a Comparative Effectiveness Research Award to attend Columbia's Summer Research Institute at Mailman School of Public Health.

Upon completing her training, Dr. Welch worked for several years as a practicing neuro-oncologist and Assistant Professor of Neurology at Montefiore Medical Center in the Bronx. There, she served as principal investigator for numerous phase I and II clinical trials for the treatment of primary and metastatic brain cancer. She also developed a strong research interest in improving patient access to both standard and investigational therapies. In addition to seeing both inpatient and outpatient neuro-oncology patients, Dr. Welch maintains an active research program within the Division of Neuro-Oncology.

Academic Titles

  • Assistant Professor of Neurology at CUMC

Committee/Societies/Council Memberships

American Academy of Neurology, Member

Society for Neuro-Oncology, Member

American Society of Clinical Oncology, Member

Alliance for Clinical Trials in Oncology, Member

NRG Oncology, Member

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Languages

  • French

Gender

  • Female

Insurance Accepted

For billing questions, please call (212) 342-4432.

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
710 West 168th Street
New York, New York 10032
Phone:
(212) 342-0571
Primary

Research

Grants

A RANDOMIZED, MULTICENTER, PHASE 2 STUDY OF DSP-7888 DOSING EMULSION IN COMBINATION WITH BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN PATIENTS WITH RECURRENT OR PROGRESSIVE GLIOBLASTOMA FOLLOWING INITIAL THERAPY (P&S Industry Clinical Trial)

Feb 6 2018 - Feb 6 2023

INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) (P&S Industry Clinical Trial)

Dec 20 2017 - Dec 20 2021

INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) - CONTROL ARM OF INSIGHT (Private)

Dec 1 2017 - Nov 30 2019

Selected Publications

Pareek V, Welch M, Ravera E, Zampolin RL, Sequist LV, Halmos B. Marked differences in CNS activity amongst EGFR inhibitors: case report and mini-review. J Thorac Oncol. 2016 Jul 24 [Epub ahead of print]

Yang Y, Haigentz M, Welch MDiplopia and Ataxia in a Heavy Smoker. JAMA 2015 September; 314(9):942-943.

Glover R, Brook A, Welch M. Teaching Neuroimages: Leptomeningeal carcinomatosis.  Neurology 2014 May; 82(21): e183-4.

Welch M, Sauter C, Matasar M, Moskowitz C, Omuro A. Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan, and cyclophosphamide. Leukemia and Lymphoma. 2015; 56(2):361-7.

Welch M, Grommes C.  Influence of anti-diabetic therapy of diabetes mellitus type II (DM) on survival in glioblastoma (GBM) patients. CNS Oncology. 2013 2(3), 237–246.

Welch M, Omuro A, DeAngelis L. Outcomes of the Oldest Patients with Primary Central Nervous System Lymphoma Treated at Memorial Sloan-Kettering Cancer Center. Neuro-Oncology. 2012 Oct; 14(10):1304-11.